http://www.fda.gov/bbs/topics/NEWS/2006/NEW01408.html
U.S. Food and Drug Administration
The Food and Drug Administration (FDA) announced approval of Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs, in a single tablet taken once a day, alone or in combination with other antiretroviral products for the treatment of HIV-1 infection in adults.